Finasteride vs minoxidil: the evidence-led comparison

Finasteride vs minoxidil at a glance

This table compares oral finasteride 1 mg with common topical minoxidil 5% label examples. It does not compare topical finasteride or oral minoxidil. Those are different formulations with different evidence, absorption and regulatory status.

Which works better?

The most defensible answer is narrower than the usual online ranking. In a 2004 open randomized study, 65 men received either oral finasteride 1 mg daily or topical minoxidil 5% twice daily for 12 months. The study reported increased hair intensity in 80% of the finasteride group and 52% of the minoxidil group. It favored finasteride, but it was small, open-label, unevenly allocated and based on a study-specific clinical endpoint. It should inform the comparison, not settle it.

A 2022 JAMA Dermatology network meta-analysis connected 23 studies and compared changes in total and terminal hair count. It found oral finasteride 1 mg more effective than topical minoxidil at the 48-week terminal-hair endpoint. A 2025 network meta-analysis covering 33 studies described finasteride 1 mg as the most effective FDA-approved oral option and topical minoxidil 5% as the most effective FDA-approved topical option. These are indirect networks, not one giant head-to-head trial.

Read the source records directly in the randomized comparison, the 2022 network meta-analysis and the 2025 update.

The practical difference: preservation vs stimulation

That difference explains why some clinicians combine them in eligible men. One addresses the androgen signal and the other supports growth. It also explains why choosing between them is not only a contest about visible regrowth at one checkpoint.

Can finasteride and minoxidil be used together?

Yes, a clinician may use them together for male pattern hair loss. The American Academy of Dermatology states that finasteride may be taken alone or used with minoxidil. A 2020 systematic review included five randomized trials and found better global photographic outcomes for combination therapy than monotherapy, although hair-density change and adverse-event counts were not significantly different. Only two of those trials compared the combination with finasteride alone.

A newer 2025 systematic review of seven randomized trials and 396 men found that a topical minoxidil-finasteride combination outperformed topical minoxidil alone on hair density, diameter and global photography. That is evidence about a topical mixed regimen, not proof that every compounded product, concentration or oral-plus-topical plan performs the same way.

Combination treatment also has a measurement cost. Starting two treatments together makes it harder to know which caused a side effect or which produced the result. It adds adherence demands and can expose someone to risks they would not accept for a small incremental benefit. That tradeoff belongs in a prescribing conversation, not an automatic online protocol.

Crown, mid-scalp and hairline are not one endpoint

Both medicines have meaningful crown evidence. Finasteride’s pivotal studies counted hairs in a fixed vertex area. The cited men’s 5% minoxidil solution is specifically labeled for regrowth on the top of the scalp, vertex only. That makes the crown the cleanest area for an evidence-based comparison.

Finasteride also has a one-year anterior mid-scalp study, but its hair counts excluded the bitemporal recessions and leading hairline. Its label explicitly says efficacy in bitemporal recession has not been established. The cited men’s minoxidil solution says it is not intended for frontal baldness or a receding hairline. These label boundaries do not prove zero response outside the measured area. They do rule out confident promises.

A region with miniaturized hairs has more medical-treatment potential than smooth skin after longstanding loss. When the question becomes surgical restoration, our crown hair transplant guide explains donor supply, whorl geometry and why stabilization matters before spending grafts.

Side effects: different risk categories

Finasteride is a systemic prescription medicine. In year one of the label’s male pattern hair loss trials, decreased libido was reported by 1.8% on finasteride and 1.3% on placebo. Erectile dysfunction was reported by 1.3% and 0.7%, and ejaculation disorder by 1.2% and 0.7%. Postmarketing reports include sexual dysfunction continuing after discontinuation, male infertility or poor seminal quality, depression, and suicidal ideation and behavior. Postmarketing reports cannot reliably establish frequency or prove causality, but they belong in informed consent.

Finasteride also lowers PSA. A prescriber and any clinician interpreting prostate tests need to know about its use. It is not indicated for women, and pregnancy is a contraindication. Women who are pregnant or may become pregnant must not handle crushed or broken tablets because of potential risk to a male fetus.

Topical minoxidil more commonly creates a local tolerance problem, including scalp irritation, redness, itching and unwanted facial hair. The labels also say to stop and ask a doctor if chest pain, rapid heartbeat, faintness, dizziness, sudden unexplained weight gain, or swelling of the hands or feet occurs. The cited men’s product says to ask a doctor before use with heart disease. The men’s and women’s labels say use may be harmful during pregnancy or breastfeeding.

Oral minoxidil is deliberately outside this comparison. Minoxidil tablets are approved for severe hypertension, not hair loss, and systemic use carries a materially different safety discussion. See our evidence-separated guide to oral minoxidil for hair loss.

What to compare before choosing a route

Read the full results guides

Frequently asked questions

Is finasteride better than minoxidil?

For men with androgenetic alopecia, one small open randomized study and indirect network analyses have sometimes favored oral finasteride on selected outcomes. That does not make it universally better. The studies use different populations, formulations, durations and endpoints. Finasteride targets DHT and is prescription-only for men; topical minoxidil has labeled products for both men and women. The relevant comparison depends on diagnosis, eligibility, safety and whether the routine is sustainable.

Can finasteride and minoxidil be used together?

They can be used together under a clinician’s plan, and the American Academy of Dermatology notes that finasteride may be used alone or with minoxidil. Systematic reviews of randomized trials suggest combination therapy can outperform monotherapy on some photographic outcomes. The evidence is heterogeneous, and combining treatments also adds cost, effort and more possible causes if side effects occur.

Which works faster, finasteride or minoxidil?

The labels allow for early signals after roughly two to four months, depending on the exact product, but neither treatment should be judged after a few weeks. Six to twelve months is a more useful visual review window. Standardized photos matter more than day-to-day mirror impressions.

Which is safer, finasteride or minoxidil?

There is no honest one-word answer because the risks differ. Finasteride is a systemic prescription drug with sexual, reproductive, psychiatric and PSA-related considerations. Topical minoxidil commonly raises scalp-tolerance issues and can cause unwanted facial hair, while its label also tells users to stop for cardiovascular or fluid-retention symptoms. A clinician can assess which risks matter for an individual.

Which works better for the crown?

Both have evidence at the crown. Finasteride’s pivotal trials measured the vertex, and the cited men’s 5% minoxidil solution is labeled for the vertex. Results still vary, and a smooth bald area with longstanding loss has less capacity for medical regrowth than an area containing miniaturized hairs.

Which works better for a receding hairline?

The evidence is less direct than it is for the crown. Finasteride has anterior mid-scalp evidence, but its label says efficacy in bitemporal recession has not been established. The cited men’s 5% minoxidil solution says it is not intended for frontal baldness or a receding hairline. Neither label supports a promise to rebuild a fully receded juvenile hairline.

What happens if I stop finasteride or minoxidil?

The treatment benefit is generally lost. Finasteride’s label says its effect reverses within 12 months after withdrawal. Topical minoxidil labels say continued use is necessary and hair loss begins again after stopping. Neither medicine permanently changes the underlying tendency to pattern hair loss.

Can women use finasteride or minoxidil?

Topical minoxidil has specific over-the-counter products labeled for women. Oral finasteride 1 mg is indicated for male pattern hair loss in men only, is not indicated for women, and is contraindicated in pregnancy. Women who are pregnant or may become pregnant should not handle crushed or broken finasteride tablets.